Advertisement

La radiologia medica

, Volume 121, Issue 9, pp 735–743 | Cite as

Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology

  • Francesco DionisiEmail author
  • Alessia Guarneri
  • Veronica Dell’Acqua
  • Mariacristina Leonardi
  • Rita Niespolo
  • Gabriella Macchia
  • Tiziana Comito
  • Maurizio Amichetti
  • Pierfrancesco Franco
  • Savino Cilla
  • Luciana Caravatta
  • Filippo Alongi
  • Giovanna Mantello
RADIOTHERAPY

Abstract

Purpose

To report the results of the first Italian survey investigating the role of liver-directed radiotherapy in the multidisciplinary approach of primary and metastatic liver cancer.

Materials and methods

A 21-item, two-section questionnaire was sent to all Italian radiotherapy centers on June 2014. The two sections aimed at: (1) evaluating the presence of a multidisciplinary liver tumor board and describing the role of radiation oncologists within the latter, (2) analyzing Radiotherapy treatment details and differences between centers.

Results

A total of 37 centers completed the survey. A multidisciplinary liver tumor board was available in most centers (73 %), with a radiation oncologist routinely attending the latter in the majority of cases (85 %). Most of the respondents considered liver-directed Radiotherapy as the third line choice when other therapies were not indicated or technically suitable. 18 centers reported the use of liver-directed radiotherapy. The majority of centers started liver irradiation after 2010. The most adopted motion management strategy was abdominal compression. The most adopted GTV-CTV expansion was 0 and 5 mm for metastases and hepatocellular carcinoma, respectively. Stereotactic body radiotherapy was the technique of choice; several treatment schedules were registered, being 45 Gy in three fractions the most reported fractionation scheme. Dose was prescribed at the PTV margin in most cases.

Conclusion

Liver-directed radiotherapy represents a new field of interest which is currently adopted by 10 % of all Italian Centers. The technical equipment seems adequate. The variations observed in the treatment regimens reflect the lack of a well-established standard schedule.

Keywords

HCC Liver metastases Radiotherapy SBRT 

Notes

Acknowledgments

We thank the AIRO and the AIRO GI Board for the support in the survey preparation and data collection.

Compliance with Ethical Standards

Funding

No funds were used in the article preparation.

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

References

  1. 1.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108CrossRefPubMedGoogle Scholar
  2. 2.
    AIRTUM Working Group (2011) Italian cancer figures, report 2011: survival of cancer patients in Italy. Epidemiol Prev. 35(5–6 Suppl 3):1–200Google Scholar
  3. 3.
    Schefter TE, Kavanagh BD (2011) Radiation therapy for liver metastases. Semin Radiat Oncol. 21(4):264–270CrossRefPubMedGoogle Scholar
  4. 4.
    Brock KK, Deformable Registration Accuracy Consortium (2010) Results of a multi-institution deformable registration accuracy study (MIDRAS). Int J Radiat Oncol Biol Phys 76(2):583–596CrossRefPubMedGoogle Scholar
  5. 5.
    Brock KK (2011) Imaging and image-guided radiation therapy in liver cancer. Semin Radiat Oncol. 21(4):247–255CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Tao C, Yang L-X (2012) Improved radiotherapy for primary and secondary liver cancer: stereotactic body radiation therapy. Anticancer Res 32(2):649–655PubMedGoogle Scholar
  7. 7.
    Guckenberger M, Sweeney RA, Wilbert J, Krieger T, Richter A, Baier K et al (2008) Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Int J Radiat Oncol Biol Phys 71(1):297–304CrossRefPubMedGoogle Scholar
  8. 8.
    NCCN Clinical Practice guidelines in Oncology (NCCN Guideline) Hepatobiliary cancers Version 2. 2014. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site. Accessed 2 Sept 2014
  9. 9.
    NCCN clinical practice guidelines in Oncology: Rectal cancer v2. 2014. http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf. Accessed 2 Sept 2014
  10. 10.
    Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD (2011) A survey of stereotactic body radiotherapy use in the United States. Cancer 117(19):4566–4572CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Lock MI, Hoyer M, Bydder SA, Okunieff P, Hahn CA, Vichare A et al (2012) An international survey on liver metastases radiotherapy. Acta Oncol Stockh Swed. 51(5):568–574CrossRefGoogle Scholar
  12. 12.
    Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M et al (2010) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):S94–S100CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Korean Liver Cancer Study Group and National Cancer Center, Korea (2009) Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol. 15(3):391–423CrossRefGoogle Scholar
  14. 14.
    European Association for the Study of the Liver (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer 48(5):599–641CrossRefGoogle Scholar
  15. 15.
    Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, ESMO Guidelines Working Group (2014) Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol ESMO. 25(Suppl 3):iii1–iii9CrossRefGoogle Scholar
  16. 16.
    Mohiuddin M, Chen E, Ahmad N (1996) Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 14(3):722–728Google Scholar
  17. 17.
    Blomgren H, Lax I, Näslund I, Svanström R (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol Stockh Swed 34(6):861–870CrossRefGoogle Scholar
  18. 18.
    Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, Wong RKS et al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 31(13):1631–1639CrossRefGoogle Scholar
  19. 19.
    Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ et al (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol Off J Am Soc Clin Oncol. 27(10):1572–1578CrossRefGoogle Scholar
  20. 20.
    Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379(9822):1245–1255CrossRefPubMedGoogle Scholar
  21. 21.
    Clark ME, Smith RR (2014) Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol. 5(5):374–387PubMedPubMedCentralGoogle Scholar
  22. 22.
    Bae SH, Kim M-S, Jang WI, Kay C-S, Kim W, Kim ES et al (2014) A survey of stereotactic body radiotherapy in Korea. Cancer Res Treat Off J Korean Cancer AssocGoogle Scholar
  23. 23.
    Wang M-H, Ji Y, Zeng Z-C, Tang Z-Y, Fan J, Zhou J et al (2010) Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume. Int J Radiat Oncol Biol Phys 76(2):467–476CrossRefPubMedGoogle Scholar
  24. 24.
    MéndezRomero A, Verheij J, Dwarkasing RS, Seppenwoolde Y, Redekop WK, Zondervan PE et al (2012) Comparison of macroscopic pathology measurements with magnetic resonance imaging and assessment of microscopic pathology extension for colorectal liver metastases. Int J Radiat Oncol Biol Phys. 82(1):159–166CrossRefGoogle Scholar
  25. 25.
    Brown JM, Carlson DJ, Brenner DJ (2014) The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys 88(2):254–262CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37(8):4078–4101CrossRefPubMedGoogle Scholar
  27. 27.
    Lausch A, Sinclair K, Lock M, Fisher B, Jensen N, Gaede S et al (2013) Determination and comparison of radiotherapy dose responses for hepatocellular carcinoma and metastatic colorectal liver tumours. Br J Radiol 86(1027):20130147CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J et al (2011) Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117(17):4060–4069CrossRefPubMedGoogle Scholar
  29. 29.
    Eriguchi T, Takeda A, Oku Y, Ishikura S, Kimura T, Ozawa S et al (2013) Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma—benchmark for a prospective multi-institutional study. Radiat Oncol Lond Engl. 8:113CrossRefGoogle Scholar

Copyright information

© Italian Society of Medical Radiology 2016

Authors and Affiliations

  • Francesco Dionisi
    • 1
    Email author
  • Alessia Guarneri
    • 2
  • Veronica Dell’Acqua
    • 3
  • Mariacristina Leonardi
    • 3
  • Rita Niespolo
    • 4
  • Gabriella Macchia
    • 6
  • Tiziana Comito
    • 5
  • Maurizio Amichetti
    • 1
  • Pierfrancesco Franco
    • 2
  • Savino Cilla
    • 7
  • Luciana Caravatta
    • 8
  • Filippo Alongi
    • 9
  • Giovanna Mantello
    • 10
  1. 1.Proton Therapy Unit, Department of OncologyAzienda Provinciale per i Servizi Sanitari, APSSTrentoItaly
  2. 2.Department of Oncology, Radiation OncologyUniversity of TorinoTurinItaly
  3. 3.Division of Radiation OncologyEuropean Institute of OncologyMilanItaly
  4. 4.Department of Radiation OncologySan Gerardo Hospital-University of Milan-BicoccaMonzaItaly
  5. 5.Radiation Oncology DepartmentHumanitas Clinical and Research Center, Italy Cancer CenterRozzanoItaly
  6. 6.Radiation Oncology Unit, Research and Care Foundation ‘Giovanni Paolo II’Catholic University of Sacred HeartCampobassoItaly
  7. 7.Medical Physics Unit, Research and Care Foundation ‘Giovanni Paolo II’Catholic University of Sacred HeartCampobassoItaly
  8. 8.Radiation Oncology Department“San Francesco” HospitalNuoroItaly
  9. 9.Radiation OncologySacro Cuore-Don Calabria HospitalNegrar-VeronaItaly
  10. 10.Department of Oncology and RadiotherapyAzienda Ospedaliero Universitaria Ospedali RiunitiAnconaItaly

Personalised recommendations